CANTOR EQUITY PARTNERS INC (CEP) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CEP • KYG4491L1041

14.27 USD
-0.16 (-1.11%)
At close: Dec 8, 2025
10.1 USD
-4.17 (-29.22%)
After Hours: 12/8/2025, 8:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CEP. CEP was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of CEP have multiple concerns. CEP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • CEP had positive earnings in the past year.
  • CEP had a negative operating cash flow in the past year.
CEP Yearly Net Income VS EBIT VS OCF VS FCFCEP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M 2M 3M

1.2 Ratios

Industry RankSector Rank
ROA 4.06%
ROE 4.14%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CEP Yearly ROA, ROE, ROICCEP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -200 -400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CEP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CEP Yearly Profit, Operating, Gross MarginsCEP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, CEP has about the same amount of shares outstanding.
  • CEP has about the same debt/assets ratio as last year.
CEP Yearly Shares OutstandingCEP Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
CEP Yearly Total Debt VS Total AssetsCEP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • CEP has an Altman-Z score of 54.26. This indicates that CEP is financially healthy and has little risk of bankruptcy at the moment.
  • CEP has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 54.26
ROIC/WACCN/A
WACCN/A
CEP Yearly LT Debt VS Equity VS FCFCEP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • CEP has a Current Ratio of 0.13. This is a bad value and indicates that CEP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CEP has a Quick Ratio of 0.13. This is a bad value and indicates that CEP is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
CEP Yearly Current Assets VS Current LiabilitesCEP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100K 200K 300K 400K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 795.78% over the past year.
EPS 1Y (TTM)795.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 41.97, the valuation of CEP can be described as expensive.
  • When comparing the Price/Earnings ratio of CEP to the average of the S&P500 Index (28.25), we can say CEP is valued slightly more expensively.
Industry RankSector Rank
PE 41.97
Fwd PE N/A
CEP Price Earnings VS Forward Price EarningsCEP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CEP Per share dataCEP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CEP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CANTOR EQUITY PARTNERS INC

NASDAQ:CEP (12/8/2025, 8:00:00 PM)

After market: 10.1 -4.17 (-29.22%)

14.27

-0.16 (-1.11%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-14
Earnings (Next)03-26
Inst Owners64.89%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change-65.78%
Market Cap182.66M
Revenue(TTM)N/A
Net Income(TTM)4.35M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 41.97
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.74
P/tB 1.74
EV/EBITDA N/A
EPS(TTM)0.34
EY2.38%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS8.21
TBVpS8.21
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.93
Profitability
Industry RankSector Rank
ROA 4.06%
ROE 4.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z 54.26
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)795.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-325.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CANTOR EQUITY PARTNERS INC / CEP FAQ

What is the fundamental rating for CEP stock?

ChartMill assigns a fundamental rating of 1 / 10 to CEP.


Can you provide the valuation status for CANTOR EQUITY PARTNERS INC?

ChartMill assigns a valuation rating of 0 / 10 to CANTOR EQUITY PARTNERS INC (CEP). This can be considered as Overvalued.


Can you provide the profitability details for CANTOR EQUITY PARTNERS INC?

CANTOR EQUITY PARTNERS INC (CEP) has a profitability rating of 0 / 10.


What are the PE and PB ratios of CANTOR EQUITY PARTNERS INC (CEP) stock?

The Price/Earnings (PE) ratio for CANTOR EQUITY PARTNERS INC (CEP) is 41.97 and the Price/Book (PB) ratio is 1.74.


How financially healthy is CANTOR EQUITY PARTNERS INC?

The financial health rating of CANTOR EQUITY PARTNERS INC (CEP) is 2 / 10.